Introduction
Microtubules are essential components of the mammalian cytoskeleton and are important in almost all key biological processes, such as cell division, cell motility and cell differentiation (e.g., into neurons, cilia and flagella, platelets). Owing to this importance, one of the key concerns of cell biology has been to mechanistically understand how these highly conserved cytoskeletal elements adapt to such a huge variety of biological functions. In vitro experiments aiming at reconstructing microtubule assemblies and functions from purified tubulin and other cytoskeletal components have been instrumental in understanding the biochemical, biophysical and structural properties of microtubules. Tubulin was discovered as the protein building block of microtubules in 1967 (ref. 1 ), and soon after, it was shown that tubulin can assemble into microtubules in solution 2 . This led to a plethora of studies on the assembly properties and mechanisms of microtubules 3, 4 , as well as how this assembly is regulated by tubulin drugs 5 and microtubule-associated proteins (MAPs) 6 . In vitro studies with tubulin have also allowed researchers to propose possible mechanisms of microtubule dynamic behavior, such as treadmilling 7 and dynamic instability 8 . The development of novel light microscopy techniques 9 and the growing availability of molecular biology tools for cloning and purifying recombinant proteins led to more and more complex in vitro reconstitutions of microtubule assemblies 10 . This resulted in a large number of amazing discoveries based on in vitro reconstitutions of microtubule assemblies, such as the self-organization of microtubules and motor proteins 11 , the reconstitution of mitotic spindle functions in minimal systems 12, 13 , the analysis of cargo transport with isolated components 14 , and the self-repair of microtubules 15 , to give a few examples.
The reliability of these experiments strongly depends on the biochemical quality of the protein components used for such reconstitution, in particular on high-quality and high-purity tubulin. For the past 50 years, virtually all in vitro reconstitutions have been performed with tubulin purified from brain tissue. Brain tubulin can be obtained in large quantities from cow, pig or sheep brain by cycles of warm polymerization and cold depolymerization 16 . This method is highly efficient because of the large abundance of tubulin in brain tissue and the capacity of tubulin to spontaneously polymerize at high protein concentrations. By cycling several times between polymerized microtubules (warm) and depolymerized soluble tubulin (cold), the method yields highly pure and assembly-competent tubulin, whereas microtubule aggregates or assembly-incompetent soluble tubulin will be eliminated in the consecutive cycles. The only 'contaminations' of thus-purified tubulin are MAPs, which can be removed either by chromatography 16 or by the polymerization of tubulin in a high-molarity buffer that disrupts the binding of MAPs to the microtubules 17 . The ease of purification of large quantities (gram amounts) of brain tubulin was highly convenient, as none of the alternative methods of purifying tubulin from other sources could reach the quality, quantity and ease of the brain tubulin preparations. Therefore, brain tubulin is still today the mostused component for in vitro reconstitutions, as well as structural studies. This massive use of brain tubulin, however, masks the fact that tubulin is heterogeneous in different organisms, cells, and even within single cells (e.g., between cytoplasmic and ciliary microtubules 18 ). Both, α-and β-tubulin are expressed from a variety of genes, giving rise to tubulin isotypes, which are further subjected to a large variety of PTMs. Both specific isotypes and PTMs mark functionally specialized microtubule populations and might confer specific properties and functions upon these microtubules. This concept, known as the 'tubulin code' 19 , is so far little explored, and one of the greatest stumbling stones was the impossibility of purifying tubulin with controlled isotypes and PTMs that could replace the brain tubulin-a heterogeneous mixture of isotypes particularly enriched in PTMs-in in vitro assays. Although a variety of alternative methods have recently emerged, we argue that it will be essential to purify tubulin with controlled PTMs using an approach that is highly similar to the established purification of brain tubulin, the gold standard in the field.
The method we describe here allows purification of tubulin from large-and medium-scale cultures of mammalian cells by cycles of polymerization and depolymerization. The quality of thus-purified tubulin is equivalent to that of brain tubulin, as demonstrated in meticulous in vitro reconstitutions [20] [21] [22] . The tubulin prepared from HeLa S3 cells has been shown to be virtually free of tubulin PTMs, and such non-modified tubulin can be selectively modified with single PTMs 20 . This is a huge advantage over brain tubulin, which contains an uncontrollable mixture of PTMs. Our efforts to downscale the purification procedure have also allowed us to set up a small-scale purification of tubulin from single mouse brains (~400 mg versus~500 g of cow brain), which has become a complementary tool for studying the functions of tubulin from an emerging plethora of mouse models with altered tubulin PTMs, isotypes, or mutations in tubulin genes.
Overview of the procedure
Our protocol is composed of three main parts. The first part describes the amplification of sources from which tubulin will be purified (Step 1): cell lines are cultured either in spinner bottles ( Step 1A) or adherently on plastic dishes (Step 1B). It is possible to transfect adherently growing cells with expression plasmids or to treat them with drugs (Box 1). We further describe how tubulin can be purified from a single mouse brain ( Step 1C).
The second section of the protocol describes the lysis procedures (Step 2): the particularities of lysis of HEK-293 cells ( Step 2A); HeLa S3, HeLa and U-2 OS cells (Step 2B); or brain tissue (Step 2C).
The third part describes the tubulin purification process itself (Fig. 1) . First, cells or tissue is lysed and the lysate is cleared (Steps 3, then Step 4A for cell extracts or Step 4B for brain extracts). Next, the first polymerization is performed in low-molarity buffer (Steps 7-11), followed by the first depolymerization step (Steps 12-17). Optionally, tubulin can then be enzymatically treated at this point (Step 18) . Tubulin is then subjected to the second polymerization (Steps [19] [20] [21] [22] [23] , this time in high-molarity buffer to avoid the binding of MAPs to the polymerized microtubules, and MAP-free microtubules are subsequently depolymerized (Steps [24] [25] [26] [27] [28] [29] [30] . A third cycle of polymerization (Steps [31] [32] [33] [34] [35] and depolymerization (Steps 36-41) in low-molarity buffer can be performed.
We then describe the qualitative and quantitative analysis of the purified tubulin (Step 42, Box 2). We propose quantification by protein-band intensity measurements on Coomassie-stained gels and qualitative analyses using immunoblot with antibodies detecting specific tubulin PTMs.
Development of the approach
When setting up this protocol, one major bottleneck was the polymerization of tubulin directly from cell extracts. The most important parameter for this to work is the tubulin concentration in the initial extract. Tubulin is, with~25% of the total soluble protein, a major component of brain extracts, whereas it constitutes only~3% in extracts from cell lines 23 . To avoid failure of tubulin polymerization due to the lower concentrations in cell extracts, we modified the first polymerization step, which in our protocol is performed at a low 1,4-piperazine ethanesulfonic acid (PIPES) molarity. This allows MAPs present in the cell extract to assist in the first round of microtubule polymerization. The molarity of PIPES is greatly increased in the second round of polymerization, in which the concentration of tubulin can be adjusted to allow efficient polymerization at high-molarity conditions.
The first key step of the protocol is the cell lysis, which should ensure that most of the cellular microtubules depolymerize into soluble tubulin. To ensure this, the procedure is carried out at 4°C, which promotes microtubule depolymerization. Second, we found that different cell types and tissues require different lysis techniques. Whereas HEK-293 cells can be disrupted by repetitive pipetting through a narrow pipette tip, HeLa S3 cells and other tested cell types require a more severe disruption procedure. Large amounts grown in spinner cultures are thus lysed using a French press, or an equivalent cell-disrupting apparatus, and small amounts are lysed by gentle sonication. Brain tissue, in contrast, is best lysed using an Ultra-Turrax homogenizer.
An unexpected problem was the difficulty of completely clarifying the first extract from lysed cells by ultracentrifugation. We encountered substantial problems with a floating layer that easily contaminates the clear supernatant but cannot be avoided by longer centrifugation times. We thus chose to carefully remove the clear supernatant between this floating layer and the pellet, even if there is some loss of cell extract at this step. We introduced an additional low-speed centrifugation step to further clarify the first supernatant. The severity of this problem varies among different cell types and can lead to complete failure of the purification procedure if too much floating material is included in the first polymerization step. Careful handling is therefore of key importance at this first step.
Box 1 | Transfection and drug treatment of adherently growing cells • Timing 1-4 h
Transfection with plasmid DNA using the jetPEI reagent c CRITICAL Note that HeLa S3 cells are very difficult to transfect using the protocol described here. We therefore recommend the following procedure.
1 Seed cells the day before the transfection, so that they are at~75% confluence. 2 Mix the jetPEI reagent gently by inverting the tube. For each 15-cm dish, dilute 50 µl of jetPEI in 450 µl of plain DMEM (without any supplement). Prepare the total volume needed depending on the number of dishes (500 µl of jetPEI in 4.5 ml of DMEM if ten dishes are used). 3 Mix well, spin briefly (1,000g, room temperature, 10 s) to collect the whole volume at the bottom of the tube, and leave under the hood for 5 min. 4 Dilute 25 µg of plasmid DNA in 500 µl of plain DMEM per dish. Prepare the total volume needed for all dishes (250 µg of DNA in 5 ml of DMEM for ten dishes). 5 Add the diluted jetPEI to the diluted DNA and vortex vigorously for 15 s. Leave under the hood for 15-30 min before transfection, without exceeding 30 min. c CRITICAL STEP Always add the diluted jetPEI to the diluted DNA, and not the other way around. Strictly observe vortexing time. This is essential in order to form transfection-efficient DNA-jetPEI complexes. 6 During the 15-min waiting time, replace the complete medium of the cells with the fresh, pre-heated medium. 7 Gently tap the DNA-jetPEI mix from step 5 and add 1 ml of it dropwise to each dish. Mix by gently swirling the dish and return it to the incubator.
Drug treatment
1 Prepare the drug with the correct dilution. For TSA, an inhibitor of the tubulin deacetylase HDAC6 (refs. 59, 60 ), add 1.2 µl of 10 mM TSA to 12 ml of fresh medium per dish (final concentration of 1 µM). Prepare enough TSA, which depends on the number of dishes (12 µl of 10 mM TSA in 120 ml of medium if ten dishes are used). 2 Leave the drug on the cells for the desired time, depending on the drug. For TSA, cells are exposed to the drug for 4 h in the cell culture incubator before cell harvest.
Comparison with other methods
Compared with its blueprint-tubulin purification from brain tissue-our method is technically more demanding for two reasons: first, the method to grow large amounts of cells must be successfully established before the method can be started, and second, the lysis step and the first clarification of the resulting lysate are more exacting than the corresponding techniques for brain tissue (see 'Development of the approach' section). Strikingly, a method similar to that described here was first used in 1979 to isolate MAPs specific to HeLa microtubules 24 , but to our knowledge, it has never been used to produce tubulin for in vitro reconstitution approaches. There were also several other successful attempts to purify assembly-competent tubulin from different sources in the 1970s (reviewed in Farrell 25 ), but none of them have been followed up, perhaps due to difficulties in reproducing the cumbersome biochemical procedures.
Organelle/vesicle Soluble proteins MAPs
Microtubule (MT)
Step at 30 °C
Step Fig. 1 | Flow scheme of the tubulin purification protocol. Different steps of the tubulin purification are schematically depicted. After the lysis and lysate clarification (Steps 2-4), the first polymerization is carried out in low-molarity conditions (polymerization 1, Steps 7-10). Microtubules are then pelleted and depolymerized, and soluble tubulin is clarified (depolymerization 1, Steps 12-15). Soluble tubulin is then subjected to a high-molarity polymerization, excluding the MAPs (polymerization 2 and depolymerization 2, Steps 19-28). After polymerization 2, it is possible to purify MAPs. Tubulin can be further subjected to a third, low-molarity polymerization, followed by depolymerization (polymerization 3 and depolymerization 3, Steps 31-39), in order to completely remove the high-molarity buffer from polymerization 2. The temperature of the step is indicated by the background color. The nature of the discarded fraction is indicated, as well as the possible pause points (optional freezing steps) and additional treatment. Approximate timing of the procedure is also given. Depol, depolymerization; pol, polymerization.
Alternative methods of purifying tubulin without the need for polymerization-depolymerization cycles have also been described. For instance, isotype-specific antibodies were used in immunoaffinity purifications to partially separate tubulin into isotype-enriched fractions 26 . Many alternative protocols are based on pre-absorption of tubulin from cell extracts onto chromatography columns 27, 28 . All these methods require chromatography equipment and specific expertise, which might be the reason they have not been broadly used.
Finally, two recent developments have considerably advanced the purification of tubulin from sources other than brain tissue: the introduction of the TOG (tumor overexpressed gene) column and purification of recombinant tubulin from insect cells. The TOG column is an affinity matrix based on a domain of the TOG protein Stu2p from budding yeast. This column uses the affinity of tubulin dimers to the TOG domain to selectively bind tubulin from cell extracts, and has been shown to produce highly pure fractions of tubulin from many different tissues and cell sources 29 . The method has so far allowed the purification of tubulin from a range of organisms, such as yeast or Caenorhabditis elegans, and the study of the structure 30, 31 and dynamics [32] [33] [34] of those evolutionarily divergent tubulins and their impact on the behavior of motor proteins 35 . One of the most remarkable recent advances was the development of a method to generate recombinant tubulin. This method is based on a bicistronic expression of an α-and a β-tubulin gene in insect cells using the baculovirus system. Both genes carry a small epitope tag, which allows for a Box 2 | Analysis of the obtained tubulin • Timing 10 min-3 h
The enrichment of tubulin can be followed throughout the purification procedure by using a Coomassie-stained SDS-PAGE gel (step 2). We also suggest quantifying obtained tubulin on an SDS-PAGE gel (step 3), because in our experience, spectrometry methods do not give a good reading of the tubulin concentration. The tubulin sample can be further analyzed for the presence of expected tubulin isotypes or PTMs by immunoblotting (step 4). We recommend using the custom-made 'TUB' gels, which allow the separation of α-and β-tubulins 58 (see 'Reagent setup' section). 2 Tubulin purification test. To verify the success and purity of the tubulin purified using this protocol, we use Coomassie-stained SDS-PAGE gels, which allow separation of α-and β-tubulins and which have been described previousely 58 (see 'Reagent setup' section). Load an equal fraction of each sample from the purification steps (see table above) to assess the enrichment of tubulin (Fig. 4a) . 3 Quantification of tubulin. We quantify the tubulin using standardized BSA samples. Load two quantities of the tubulin sample (e.g., 0.05 µl and 0.1 µl of SN7) on an SDS-PAGE gel next to a range of known quantities of BSA protein (0.5 µg, 1 µg, 2 µg, 3 µg). After staining the gel with Coomassie brilliant blue and scanning it, deduce the concentrations of α-and β-tubulins in your sample by using the linear regression of the BSA-band intensities. If using the 'TUB' SDS-PAGE gels, note that α-and β-tubulins will have to be quantified separately. c CRITICAL STEP Make sure the scanner is set to a linear range and do not manipulate the contrast setting, in order to allow a correct determination of relative intensities of the analyzed bands. 4 Analysis of obtained tubulin by immunoblot (Fig. 4b-d) . To confirm the presence of the desired tubulin PTMs, we recommend immunoblot analysis. On the basis of the quantification of the purified tubulin, load between 0.1 and 0.2 µg of tubulin on a 'TUB' SDS-PAGE gel (allowing separation of α-and β-tubulins
Procedure

58
; see 'Reagent setup' section). As the antibodies toward tubulin PTMs are very specific and give strong signals even at low tubulin concentrations, it is critical to load a small amount of the tubulin sample. We also avoid incubating the membranes with the antibodies for more than 2 h at room temperature. Always check the equal loading of your samples by performing an immunoblot with a PTM-independent anti-α-tubulin antibody (12G10) and include a positive control, for example, brain tubulin. ? TROUBLESHOOTING two-step affinity purification of dimers exclusively composed of the recombinant α-and β-tubulin 36 . This method now allows the systematic study of the role of different tubulin isotypes 31, 37, 38 and tubulin mutations 39 in vitro; however, it is a cumbersome and time-consuming method to establish, and thus only dedicated labs might decide to commit to it.
Advantages, limitations and applications
The great advantage of the method described here is the possibility of rapidly producing milligram amounts of pure, assembly-competent tubulin from cell lines. When using spinner bottles with HeLa S3 cells, the method can be run in the background, and requires only a couple of hours per week for cell harvesting and re-inoculation of new spinners, and 1 d per week if tubulin purification is carried out immediately (alternatively, cells can be stored in lysis buffer at −80°C and a larger-scale purification can be performed after collecting several rounds of spinner cultures). This tubulin can, in a simple and straightforward step, be converted to detyrosinated tubulin, thus providing two pure PTM versions of tubulin: one totally tyrosinated (non-treated) and one totally detyrosinated (after treatment) 20 .
In combination with the overexpression of specific tubulin-modifying enzymes, our approach can easily be extended to other tubulin PTMs. Finally, our protocol allows fast and efficient purification of tubulin from single mouse brains, which in light of a growing number of transgenic mouse models with altered tubulin PTMs or isotypes, or with tubulin mutations, provides great opportunities to study the impact of these alterations directly in vitro.
A limitation of our system is its restriction to the native tubulin isotype composition of the cell line used for the tubulin purification. However, all cell lines analyzed so far express rather 'generic' α-and β-tubulin isotypes, i.e., isotypes with high sequence homologies, which makes such tubulin more homogeneous than brain tubulin, which is composed of a significant amount of the rather divergent β3-tubulin (TUBB3) isotype 40 . A second limitation of the method described here is that specific tubulin isotypes, or tubulins carrying particular PTMs, might polymerize less efficiently, or depolymerize less if they strongly stabilize microtubules. They could therefore be lost or disproportionally reduced during the purification. One striking example is polyaminated tubulin, which is completely excluded in the brain tubulin purification procedure 41 . However, we have shown that the currently most-studied tubulin modifications, such as acetylation, detyrosination, glutamylation and glycylation, are preserved throughout our protocol (see 'Anticipated results' section). Thus, although for quantitative studies of tubulin modifications or isotype composition, the TOG column should be the method of choice 29 , our protocol is appropriate for meticulous in vitro reconstructions in which the high purity and assembly competence of tubulin are key [20] [21] [22] . Our method could fully replace the standard brain tubulin preparation, allowing the use of tubulin free of PTMs and assembled from less-divergent tubulin isotypes on a daily basis. A typical 4-liter spinner culture of HeLa S3 cells yields~15 g of cells, which in our experience gives rise to~2 mg of tubulin (corresponding to a yield of~135 µg/g). This is lower than the yield from adherent cells, which is~200 µg/g; however, growing cells on plastic dishes is more time consuming and, in particular, harvesting them from the dishes is more cumbersome. We found that ten is the maximum number of 15-cm dishes that can be handled; this number gives rise to~1.2 g of cells, yielding 250 µg of pure tubulin. The lower yield of cells in suspension culture could be related to a less complex microtubule cytoskeleton in these spherical cells; however, this is not a major concern, as spinner cultures are effortlessly grown in large quantities. Overall, cycling of tubulin is bound to engender some loss, which is why it is not surprising that Widlund et al. 29 report three times higher tubulin yields (~460 µg/g) from human cells using the TOG column.
Finally, our protocol yields~1 mg/g of tubulin from mouse brains, which is higher as compared to the standard yield from pig brain that in our experience is~400 µg/g. This is most likely related to the longer post mortem delay of the pig brains as compared to the instantly available mouse brains. Tubulin purified from single mouse brains can be used to directly test the in vitro behavior of microtubules from a growing number of mouse models with altered tubulin isotype composition [42] [43] [44] or tubulin PTMs 45, 46 .
Experimental design
Scaling up the tubulin production in spinner cultures Although our method also works for relatively small amounts of adherently growing cells, spinner cultures to grow cells in suspension are fundamental to obtaining milligram amounts of tubulin. The setup we propose here allows the growth of 4 × 1 liter of suspension cultures in parallel, which yield~15 ml of cell pellet every 7 d, allowing for the purification of~2 mg of tubulin. We can also purify tubulin from two spinner bottles, but not fewer, as at lower amounts the procedure becomes unreliable. HeLa S3 cells, which have been optimized for growth in suspension, do not agglutinate and can thus be grown and harvested, and re-diluted in parallel for several weeks or months, without preparing new adherent pre-cultures. Other cells, such as HEK-293 cells, have the tendency to form cell aggregates during growth in suspension, which makes it necessary to inoculate them each time from an adhered pre-culture, which is more time consuming and work intense. The advantage of HEK-293 cells is the ease of generating stable, inducible cell lines with the Flp-In T-REx 293 cell line.
Using a variety of cell and tissue sources to generate custom-modified tubulin Smaller amounts of tubulin can also be purified from adherently growing cells. The advantage of this approach is that it allows the use of any cell line; treatment of the cells before tubulin isolation, e.g., by transfecting expression vectors to express tubulin-modifying enzymes or tubulin isotypes; or treatment of the cells with drugs, all of which would be difficult to impossible in cells growing in suspension culture. Another advantage is that specific equipment, such as spinner bottles, is not needed. The drawback is that only small amounts of tubulin can be produced (~250 µg for ten 15-cm dishes), and that the method is less easily reproducible, as small variations in cell numbers or delays during the cell harvest can have a strong impact on the efficiency of tubulin polymerization, and thus on the yield. So far, we have successfully prepared tubulin from HeLa, U-2 OS and HEK-293 cell lines. Having downscaled the protocol to very small volumes, it now obviously allows isolation of tubulin from very small amounts of brain tissue, i.e., from single brains of transgenic mice.
Materials Biological materials
• Mouse brain tissue. The mice used here had a C57b/6N background (Charles River Laboratories, cat. no. C57BL/6NCrl); however, any mouse strain can be used to purify tubulin from brain. Atat1 −/− mice lack tubulin acetylation and have been described before 47 . Ttll1 −/− mice, lacking one of the major brain tubulin polyglutamylases, have been described before 45 . ! CAUTION Any experiments involving mice must conform to relevant institutional and national regulations. Animal care and use for this study were performed in accordance with the recommendations of the European Community (2010/63/UE). Experimental procedures were specifically approved by the ethics committee of the Institut Curie CEEA-IC #118 (authorization no. 04395.03, given by the national authority) in compliance with international guidelines.
Cell lines ! CAUTION The cell lines used should be regularly checked to ensure that they are authentic and are not contaminated with mycoplasma.
c CRITICAL A minimum of one vial of each cell line is necessary to start this protocol.
• HeLa S3 cells (ATCC, cat. no. CCL-2.2) c CRITICAL HeLa S3 cells have been specifically selected to be able to grow both in adherent and in suspension cultures.
• Flp-In T-REx 293 cells (Thermo Fisher, cat. no. R78007) • N, N, N′, N′-Tetramethylethylenediamine (TEMED; Sigma-Aldrich, cat. no. 9281) ! CAUTION TEMED is corrosive, toxic and causes burns; use eye and skin protection.
• Ammonium persulfate (APS; Sigma-Aldrich, cat. no. A3678) • Glycine (Sigma-Aldrich, cat. no. G8898)
Antibodies
• Anti-α-tubulin antibody 12G10 (used at a 1:500 (vol/vol) ratio; developed by J. Frankel and M. Nelson, obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute of Child Health and Human Development (NICHD), and maintained by the University of Iowa) • Anti-detyrosinated tubulin antibody (used at a 1:1,000 (vol/vol) ratio; Merck, cat. no. AB3201) • Anti-tyrosinated tubulin antibody YL1/2 (used at a 1:1,000 (vol/vol) ratio; Abcam, cat. no. ab6160) • Anti-glutamylated tubulin antibody GT335 (used at a 1:20,000 (vol/vol) ratio; AdipoGen, cat. no.
AG-20B-0020) • Anti-acetylated tubulin antibody 6-11B-1 (used at a 1:2,000 (vol/vol) ratio; Sigma, cat. no. T6793) • Anti-polyglutamylated tubulin antibody polyE (used at a 1:20,000 (vol/vol) ratio; AdipoGen, cat. no.
AG-25B-0030) • Anti-mouse HRP-conjugated antibody (used at a 1:10,000 (vol/vol) ratio; Bethyl, cat. no. A90-516P)
• Anti-rabbit HRP-conjugated antibody (used at a 1:10,000 (vol/vol) ratio; Bethyl, cat. no. A120-201P) Equipment • 1.5-and 2-ml Tubes (Eppendorf, cat. nos. 0030125150 and 0030120094) c CRITICAL Do not use tubes other than these Eppendorf tubes because of possible differences in materials.
• Round-bottom tubes (14 ml CRITICAL None of the buffers used for the tubulin prep should contain sodium salts; always use potassium! Ethanol 70% (vol/vol) To prepare 70% (vol/vol) ethanol, mix 700 ml of absolute ethanol and 300 ml of water. Store at room temperature (20°C) and use as long as it is not contaminated.
Complete cell culture medium Cell culture medium is 1 liter of DMEM supplemented with 10% (vol/vol) FBS (100 ml), 200 mM Lglutamine (10 ml), and 1× penicillin-streptomycin (10 ml). Store at 4°C and use as long as it is not contaminated.
Trichostatin A, 10 mM To prepare 10 mM TSA, dissolve 1 mg of TSA in 330.7 µl of DMSO. Aliquot and store at −20°C for up to 3 years. ! CAUTION DMSO can enhance cell and skin permeability of other compounds. Avoid contact and use skin and eye protection. EDTA, 0.5 M, pH 8 To prepare 0.5 M EDTA, pH 8, dissolve 36.5 g of EDTA in water to a final volume of 250 ml, adjust the pH to 8.0 with KOH (otherwise, the EDTA will not dissolve), filter-sterilize or autoclave and store at room temperature indefinitely.
PBS-EDTA, 5 mM
To prepare 5 mM PBS-EDTA, add 5 ml of 0.5 M EDTA to 500 ml of PBS. Filter-sterilize and store at 4°C for up to 3 years (before each use, visually verify that the solution is not contaminated).
PBS-EDTA-TSA, 5 µM
To prepare 5 µM PBS-EDTA-TSA, add 25 µl of 10 mM TSA to 50 ml of 5 mM PBS-EDTA. This solution is used to detach cells treated with TSA. It should be prepared freshly before use.
KOH, 10 M To prepare 10 M KOH, dissolve 140 g of KOH in water to a final volume of 250 ml. Store at room temperature indefinitely.
K-PIPES, 0.5 M, pH 6.8 To prepare 0.5 M K-PIPES, mix 75.5 g of PIPES with water, followed by addition of KOH (otherwise, the PIPES will not dissolve). Adjust the pH to 6.8 with KOH, and make up the final volume to 500 ml. Filter-sterilize or autoclave and store at 4°C for up to several months.
K-PIPES, 1 M, pH 6.8
To prepare 1 M K-PIPES, mix 15.1 g of PIPES with water, followed by addition of KOH (otherwise, the PIPES will not dissolve). Adjust the pH to 6.8 with KOH, and make up the final volume to 50 ml. Filter-sterilize or autoclave and store at 4°C for up to several months.
K-EGTA, 0.5 M, pH 7.7 To prepare 0.5 M K-EGTA, dissolve 47.5 g of EGTA in water, adjust the pH to 7.7 with KOH, and make up the final volume to 250 ml. Filter-sterilize and store at room temperature indefinitely. Triton X-100, 10% (vol/vol) To prepare 10% (vol/vol) Triton X-100, mix 5 ml of Triton X-100 with 45 ml of water. Filter-sterilize and store at room temperature indefinitely. GTP, 0.2 M, pH 7.5 To prepare 0.2 M GTP, dissolve 1 g of GTP in 9.5 ml of water and adjust the pH to 7.5 with KOH. Make aliquots and store at −20°C for up to 6 months. Avoid repetitive freeze-thaw cycles.
Lysis buffer
Tris-HCl, 1 M, pH 6.8 To prepare 1 M Tris-HCl, dissolve 60.56 g of Tris in 500 ml of water. Adjust the pH to 6.8 with HCl, filter-sterilize or autoclave the solution and store it at room temperature indefinitely.
Laemmli sample buffer, 5× For 40 ml of 5× Laemmli sample buffer, heat 16 ml of 1 M Tris-HCl, pH 6.8; add 4 g of SDS (from VWR); and mix gently. Add 2.6 g of DTT and 20 ml (or 24 g) of 100% (vol/vol) glycerol. Add 2.5 mg of bromophenol blue to obtain the right color intensity. The final concentrations are 450 mM DTT, 10% (wt/vol) SDS, 400 µM Tris-HCl, pH 6.8, 50% (vol/vol) glycerol,~0.006% (wt/vol) bromophenol blue. Make aliquots of the desired volume and store indefinitely at −20°C.
Acrylamide-bis-acrylamide 'TUB' mix To prepare the acrylamide-bis-acrylamide 'TUB' mix, dissolve 2.7 g (0.54% (wt/vol)) of bisacrylamide powder in 500 ml of 40% acrylamide solution. Stir overnight at 4°C; then store at 4°C for up to 6 months.
SDS 'TUB', 20% (wt/vol) For 500 ml of 20% (wt/vol) SDS 'TUB' solution, dissolve 100 g of SDS in water to a final volume of 500 ml. Filter-sterilize and store at room temperature indefinitely. Heat to 40-50°C if precipitate forms. Stack gel 'TUB' buffer, 4× For 100 ml of 4× stack gel 'TUB' buffer, dissolve 6 g of Tris in 80 ml of water. Adjust the pH to 6.8 with HCl. Add 2 ml of 20% (vol/vol) SDS stock and make up the volume to 100 ml with water. The final concentrations are 0.5 M Tris, pH 6.8, 0.4% (vol/vol) SDS. Filter-sterilize and store at room temperature indefinitely.
SDS-PAGE 'TUB' gel, 10% (vol/vol) For 10 ml of SDS-PAGE 'TUB' resolving gel, mix 5 ml of water, 2.5 ml of acrylamide-bis-acrylamide 'TUB' mix, 2.5 ml of 4× resolving gel 'TUB' buffer, 80 µl of 10% (wt/vol) APS and 10 µl of TEMED; then pour the gel into an appropriate gel stand. Add no more than 300 µl of water on top of the gel and let it polymerize undisturbed for at least 20 min. For 3 ml of the stack gel, mix 1.93 ml of water, 320 µl of acrylamide-bis-acrylamide 'TUB' mix, 750 µl of 4× stack gel 'TUB' buffer, 18.5 µl of 10% (wt/vol) APS and 7.4 µl of TEMED. Remove the water from the polymerized resolving gel, add the stack gel mix, insert the appropriate comb (avoiding air bubbles), and let it polymerize undisturbed for at least 20 min. Keep at room temperature and use the same day.
SDS-PAGE 'TUB' running buffer, 1× For 1 liter of 1× SDS-PAGE 'TUB' running buffer, dissolve 28.75 g of glycine and 6 g of Tris in 900 ml of water. Add 5.75 ml of 20% (wt/vol) SDS 'TUB', and make up the volume to 1 liter with water. Store at room temperature for up to 6 months.
Equipment setup
Biological stirrer
The biological stirrer should be set inside the cell culture incubator. The rotation speed should be 25 r.p.m. for HeLa S3 and HEK-293 cells; for other cell types, it should be empirically determined.
Blender Set at power 4 or 5, which corresponds to~20,000-25,000 r.p.m. This should be sufficient to lyse the brain tissue by blending two or three times for 10-15 s.
Sonicator
We use the 6.5-mm-diameter probe fixed to the 1/2 horn (20 kHz), set to 'output control' 1 (~1.2 W/mm 2 ), 'duty cycle' 10% (0.1 s of pulse every second) and time depending on the cell type used.
French press
We use the French press at medium ratio, and with a gauge pressure of 1,000 p.s.i. (which corresponds to 3,000 p.s.i. inside the disruption chamber).
Ultracentrifuges
If two ultracentrifuges are available, one should be set to 4°C, the other to 30°C. If only one is available, set it first to 4°C and then change the temperature to 30°C during Steps 7, 19 and 31, and change it back to 4°C during Steps 12, 24 and 36. It is important to pre-cool or pre-heat the centrifuge before the run, as this will allow the centrifuge to start faster for the actual run.
Ultracentrifuge rotors
If two rotors are available, one should be stored at 4°C, the other at 30°C. If only one is available, pre-cool it first to 4°C, then heat it to 30°C during the polymerization steps and cool down again during the depolymerization steps. To efficiently change the rotor temperature, you can put it in a watertight plastic bag (to avoid wetting) and put it either on ice or in a water bath. The temperature of the rotor should always match the temperature of the sample and that of the centrifugation step, on one hand to keep the sample in optimal conditions (e.g., to not depolymerize microtubules by putting a warm sample into a cold rotor), and on the other hand to allow for a faster starting of the centrifuge.
Water bath
The water bath should be set to 30°C.
Spinner bottle cleaning
It is important to keep the spinner vessels clean and dry. We recommend the following procedure: 1 Once the cells are collected from the spinner bottles, immediately fill them with tap water, to avoid the drying of the remaining cells and their sticking to the glass. 2 As soon as possible, remove the glass ball and wash it. Rinse spinner bottles thoroughly with water, using a bottle brush if necessary. c CRITICAL Avoid using detergent, as trace amounts of unrinsed detergent could hamper the cell growth during the next culture cycle. 3 Reassemble the spinner bottle with the glass ball, add~200 ml (or enough to cover the glass ball) of deionized water and autoclave them. -iii) ). Revive the desired cell type in its preferred medium. Amplify the cells to obtain~3 × 10 7 cells (day −13). (ii) Plate these cells on a minimum of six 15-cm-diameter dishes at~0.5 × 10 7 cells per dish. Cells from six 80-90% confluent 15-cm plates will be needed to inoculate 2 liters of suspension culture (two spinners), which is the minimum of cells for a successful purification. Prepare enough cells to inoculate the desired number of spinners (day −10). (iii) Add 1 liter of pre-warmed complete medium to each spinner bottle and incubate on the stirrer table in the cell culture incubator at 20-25 r.p.m. This step allows for the medium to equilibrate in regard to temperature and pH (day −8). c CRITICAL STEP To minimize the number of operations, and the risk of contaminations, add all supplements for 1 liter of complete medium to one of the two 500-ml DMEM bottles, and add this together with the non-supplemented 500 ml of DMEM directly to the spinner bottle. c CRITICAL STEP To avoid bacterial or fungal contaminations, thoroughly clean the medium bottles and spinner bottles with 70% (vol/vol) ethanol before transferring them to the cell culture hood. c CRITICAL STEP Stir only spinner bottles filled with medium. Stirring empty bottles can result in damage. Slightly open the lateral valves of the spinner bottles to allow the incubator atmosphere to enter the bottle. CRITICAL STEP The rest of the protocol refers to a hypothetical cell pellet of 10 ml (+10 ml of lysis buffer), but a minimum of a 6-ml pellet (two spinner bottles) is sufficient for a successful purification. Adjust all measurements to the real volume of your cells in each experiment. j PAUSE POINT Once resuspended in lysis buffer, the cells can be snap-frozen in liquid nitrogen and stored at −80°C for up to 2 months. (xxi) Clean the spinner bottles after use (see 'Equipment setup' section). Remove the medium from sets of three dishes, inclining them slightly to facilitate aspiration of all the medium. c CRITICAL STEP A rapid cell harvest is very important for the success of the tubulin purification and should not take >15 min for ten 15-cm dishes. For optimal results, at least the first time this experiment is carried out, three people should participate in this step. Later, one experienced person can handle the rapid detachment of the cells. CRITICAL STEP The rest of the protocol refers to a hypothetical cell pellet of 10 ml (+10 ml of lysis buffer), but a minimum of an~1-ml pellet (from 10 15-cm dishes) is sufficient for a successful purification. Adjust all measures to the real volume of your cells in each experiment. j PAUSE POINT Once resuspended in lysis buffer, the cells can be snap-frozen in liquid nitrogen and stored at −80°C for up to 2 months. 1A(xiv-xxi) ): cells grown for 7 d in spinners are transferred to 1-liter bottles and pelleted. Cells are resuspended in PBS and transferred to a 50-ml conical tube and pelleted again. The pellet volume is recorded, and the cells are resuspended in the same volume of lysis buffer. b, The setup used to lyse the cells: whereas HeLa S3 cells are broken using a French press, HEK-293 cells are lysed by repeated passages through a p1000 tip tightly fitted to a 5-ml pipette (Step 2A(i) ). Both HEK-293 and HeLa S3 cell lysates are then repeatedly passed through a p200 tip fitted to a p1000 tip on a p1000 pipette ( Step 2A(ii) and 2B(ii)). c, Representative images of HeLa S3 and HEK-293 cells before and after lysis (Step 2A and 2B) . Note the presence of cell debris (purple crosses) in the lysates. Scale bars, 50 µm. d, Images of the purification process (Steps 3-28): after ultracentrifugation, cleared cell lysates contain a white floating layer (arrowhead), which, if mixed with the supernatant, makes it turbid (*). The supernatant can be efficiently clarified in a low-speed centrifugation step. The first-polymerization microtubule pellet has a white and uneven appearance (#). Following the first depolymerization and cold centrifugation, a pellet is well visible ($). The second polymerization gives a clear and transparent pellet (€). The second depolymerization produces a very small, hardly visible microtubule pellet (»). The temperature of the step is indicated by the color of the background: blue, 4°C; pink, 30°C.
(C) Mouse brain • Timing~15 min (i) Sacrifice the animal by cervical elongation, open the skull with scissors and extract the brain. Wash the brain briefly in lysis buffer to remove excess blood. ! CAUTION Animal experimentation is subject to specific legislation in each country; ensure that you have all necessary permits to work with mice. j PAUSE POINT It is possible to snap-freeze brains in liquid nitrogen and store them at −80°C before proceeding to the lysis. Frozen mouse brains can be stored at −80°C for up to 3 years.
(ii) Add 500 µl of lysis buffer per adult mouse brain to a round-bottom tube. c CRITICAL STEP Round-bottom tubes are essential for correct homogenization of the brain tissue, as the probe is too large to reach the tissue in a conical-bottom tube. c CRITICAL STEP The rest of the protocol refers to a hypothetical tissue volume of 10 ml (+10 of ml lysis buffer), but a minimum of one mouse brain is sufficient for a successful purification. Adjust all measures to the real volume of your cells in each experiment. (Fig. 3b ) or a p1000 micropipette should be used. The pipetting should be done on ice, for 1 min every 5 min, for 15 min (three times). (ii) Continue pipetting the solution on ice, using a p200 tip stuck to the p1000 tip (Fig. 3b) (i) Lyse the HeLa S3 cells (from spinner culture) using a French press (set to medium ratio, with gauge pressure set to 1,000 p.s.i.) or an equivalent piece of cell lysis equipment. For adherently grown cells (HeLa, U-2 OS), sonicate the cells gently, using the 6.5-mmdiameter probe fixed to the 1/2 horn (20 kHz) set to 'Output control' = 1 (~1.2 W/mm 2 ), 'Duty cycle' = 10% (0.1 s of pulse every second) and~45 pulses. Sonicate the cells in a 14-ml round-bottom tube that has been cut in height to accommodate the probe. c CRITICAL STEP The sonication should be gentle in order to avoid damaging the tubulin, but sufficient to lyse the cells. Check the lysis of the cells every 15 pulses (Fig. 3c) .
Cell and tissue lysis
(ii) Pipette cells through a p200 tip stuck to the p1000 tip (Fig. 3b) Alternatively, homogenize the brain tissue using a potter homogenizer or a microtube potter, followed by thorough tissue dissociation using rapid pipetting up and down in a 1-ml syringe with an 18-gauge needle. 
Beckman no. 355631 tubes can be centrifuged half-filled; however, for volumes <10 ml, we recommend using several Beckman no. 349622 tubes. 4 Remove the supernatant (SN1) by following option A for cell extracts and option B for brain extracts.
(A) Cell extracts • Timing ∼20 min (i) Remove the supernatant gently and without perturbing the floating layer, using a syringe with a needle. For volumes <4 ml, use a 20-gauge needle on a 5-ml syringe; for higher volumes use the long, 21-gauge needle on a syringe of appropriate volume. c CRITICAL STEP To avoid stirring the solution, remove the supernatant directly when taking tubes out of the centrifuge (instead of carrying them to the bench or placing them in an ice box).
(ii) Enter the needle into the supernatant and slowly draw off the liquid by gently moving the needle tip down toward the pellet. As soon as you observe entry of the floating layer into the syringe, stop. It is important to remove all the supernatant at once; going back and forth with the needle leads to rapid contamination of the clear supernatant. (iii) Record the volume of SN1. For a 10-ml cell pellet, SN1 should be~12 ml. c CRITICAL STEP Removing clear supernatant is straightforward for brain lysates, from which solid pellets are obtained. It is more difficult for cell extracts, which yield very unsteady pellets and a floating unstable layer of material on the top of the supernatant. This material should not be transferred to the next step, as it tends to interfere with the efficiency of tubulin polymerization. (iv) (Optional) If, despite your efforts, the supernatant is cloudy, transfer it to a 15-or 50-ml tube and centrifuge at 5,000g at 4°C for 10 min (Fig. 3d) . (B) Brain extracts • Timing ∼10 min (i) Place the tubes on ice. Remove the supernatant (SN1) with a micropipette of the right volume. (ii) (Optional) If the supernatant is cloudy, transfer it to a 15-or 50-ml tube and centrifuge at 5,000g at 4°C for 10 min (Fig. 3d) . c CRITICAL STEP Do not freeze the clarified lysates. Proceed at least until Step 10. 5 Take an aliquot of 1/100th the volume of the SN1 for analyses (120 µl for 12 ml of SN1). Add the same volume of 2× Laemmli buffer and boil for 5 min. j PAUSE POINT The SN1 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2). 6 Resuspend the pellet (P1) in BRB80 (use the same volume as that of SN1) and retain an aliquot of 1/100th of its volume (∼200 µl for ∼20 ml of P1) for analyses. Add the same volume of 2× Laemmli buffer and boil for 5 min. Discard the remaining P1. j PAUSE POINT The P1 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2).
First polymerization in low-molarity buffer • Timing ∼1 h 7 Prepare the polymerization mix in a screw-cap tube of appropriate volume at room temperature:
• 1 volume of SN1 (12 ml)
• 1/200th volume of 0.2 M GTP (60 µl), final concentration = 1 mM • 0.5 volume of glycerol (6 ml), pre-heated to 30°C (glycerol volume is not considered in calculations, as it is used as a crowding agent). 8 Mix well, avoiding air bubbles, and transfer to one or several room-temperature ultracentrifuge tubes of an appropriate volume. Equilibrate the weight of the tubes in the process (in pairs). c CRITICAL STEP Proceeding to the polymerization step directly in centrifuge tubes equilibrated for centrifugation avoids the risk of depolymerizing the microtubules when pipetting the solution after polymerization. 9 Cover the tubes with Parafilm and transfer them to a 30°C water bath. Let polymerization proceed for 20 min. c CRITICAL STEP In our experience, the efficiency of polymerization at 30°C is equivalent to that at 37°C, which is why we opted for 30°C. We restricted the polymerization time to 20 min (max. = 30 min), as longer incubation did not increase yields.
10 Spin down the polymerized microtubules at 150,000g at 30°C for 30 min. The pellet (P2; Fig. 3d) contains polymerized microtubules with associated MAPs, as well as other precipitated proteins. The supernatant (SN2) contains non-polymerized tubulin and other soluble proteins that do not bind microtubules.
? TROUBLESHOOTING j PAUSE POINT The microtubule pellet can be snap-frozen in liquid nitrogen and stored at −80°C for up to 1 year. 11 Take an aliquot of 1/200th of the volume of SN2 for analyses (90 µl for 18 ml of SN2). Add 90 µl of 2× Laemmli buffer and boil for 5 min. The remaining SN2 can be discarded. j PAUSE POINT The SN2 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2).
First depolymerization • Timing ∼1 h 12 Transfer the tube with the microtubule pellet (P2) on ice, and add 1/60th (= 200 µl, for tubulin from cells) or 1/20th (= 600 µl, for tubulin from brains) of the volume of SN1 (= 12 ml) of ice-cold BRB80 and leave on ice for 5 min. 13 Pipette vigorously up and down with a p1000 micropipette to resuspend and depolymerize the microtubules. Avoid air bubbles (Fig. 3d ). 14 Continue pipetting up and down with a p200 micropipette until the suspension is homogeneous.
Leave on ice for 20-30 min, pipetting up and down every 5 min. c CRITICAL STEP The high efficiency of this step is fundamental to the overall yield of the tubulin purification. Give it the time and patience it needs. c CRITICAL STEP In our experience, the efficiency of polymerization at 30°C is equivalent to that at 37°C, which is why we opted for 30°C. We restricted the polymerization time to 20 min (max. = 30 min), as longer incubation did not increase yields.
22 Sediment the polymerized microtubules at 150,000g at 30°C for 30 min. The pellet (P4) contains polymerized microtubules. The supernatant (SN4) contains the MAPs, as well as small amounts of non-polymerized tubulin and other soluble proteins (Fig. 3d) . c CRITICAL STEP Remove the supernatant very carefully, in order to eliminate a maximum of MAPs from the microtubule pellet. Note that with each polymerization cycle the amount of nonpolymerizing tubulin, as well as non-depolymerizable microtubules, decreases. ? TROUBLESHOOTING j PAUSE POINT The microtubule pellet (P4) can be snap-frozen in liquid nitrogen and stored at −80°C for up to 1 year. For further use of MAPs, SN4 can be snap-frozen in liquid nitrogen and stored at −80°C for up to 3 years. As the MAPs are in the polymerization buffer, which contains high PIPES and glycerol concentrations, a buffer exchange is required before further use. 23 Take a 1-to 4-µl aliquot of SN4 for analyses. Add 9 volumes of 2× Laemmli buffer and boil for 5 min. j PAUSE POINT The SN4 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2). c CRITICAL STEP In our experience, the efficiency of polymerization at 30°C is equivalent to that at 37°C, which is why we opted for 30°C. We restricted the polymerization time to 20 min (max. = 30 min), as longer incubation did not increase yields. 34 Sediment the polymerized microtubules at 150,000g at 30°C for 30 min. The pellet (P6) contains polymerized microtubules. The supernatant (SN6) contains small amounts of non-polymerized tubulin.
j PAUSE POINT The microtubule pellet can be snap-frozen in liquid nitrogen and stored at −80°C for up to 1 year. 35 Take a 1-to 4-µl aliquot of SN6 for analyses. Add 9 volumes of 2× Laemmli buffer and boil for 5 min. The rest of SN6 can be discarded. j PAUSE POINT The SN6 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2).
Third depolymerization • Timing ∼1-4 h 36 Place the tube with the microtubule pellet (P6) on ice, add 1/100th (= 120 µl, for tubulin from cells) or 1/40th (= 300 µl, for tubulin from brains) of the volume of SN1 (= 12 ml) of ice-cold BRB80 to the microtubule pellet (P6) and leave on ice for 5 min. 37 Pipette vigorously up and down with a p200 micropipette to resuspend and depolymerize microtubules. Avoid air bubbles. 38 Continue pipetting up and down with a p20 pipette until the suspension is homogeneous. Leave on ice for 20-30 min, pipetting up and down every 5 min. 39 Transfer the tubulin solution to a cold 1.5-ml Beckman no. 357448 tube. Spin down the insoluble components at 150,000g at 4°C for 20 min. The supernatant (SN7) contains pure, depolymerized tubulin. The pellet (P7) contains non-depolymerized microtubules. Transfer SN7 to a new 1.5-ml conical tube on ice. 40 Take a 1-to 4-µl aliquot of SN7 for analyses. Add 9 volumes of 2× Laemmli buffer and boil for 5 min. j PAUSE POINT The SN7 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2). 41 Resuspend the pellet (P7) in BRB80 (use the same volume as that of SN7) and keep a 1-to 4-µl aliquot of for analyses. Add 9 volumes of 2× Laemmli buffer and boil for 5 min. The rest of P7 can be discarded. j PAUSE POINT The P7 sample for analyses can be stored at −20°C for up to 1 year. Once all samples are collected, the quality of the purification is determined in Step 42 (Box 2). 42 Quantify the protein content of SN7 (see Box 2 for more details). 43 Make aliquots of SN7 by dividing it into small volumes in order to avoid future freeze-thaw cycles, snap-freeze in liquid nitrogen and store at −80°C. j PAUSE POINT Purified tubulin samples can be stored at −80°C until needed. We have not observed any decrease in polymerization activity after storage for up to 5 years.
Troubleshooting
Troubleshooting advice can be found in Table 1 . 
Anticipated results
The key application of the tubulin purification protocol described here is the advanced in vitro reconstitution of microtubule assemblies using tubulin purified from cell lines or mouse brains with controlled tubulin PTMs. The rationale of our approach was to adapt the method that is considered the gold standard for tubulin purification, the repeated polymerization and depolymerization of brain Lack of expected modification on purified tubulin
Failed transfection of cells or drug treatment
Use freshly thawed cells, check the quality of plasmid DNA, adapt drug treatment protocol Overloading of the SDS-PAGE gel with the sample Dilute the sample to load 0.2-0.5 µg of tubulin tubulin, to purify tubulin from other sources. Using our protocol, we obtain reproducible highquality, highly pure tubulin (Fig. 4a) . Owing to the relatively small sample sizes (as compared with the previously used brain-tubulin purification), our protocol shows some variation in yield, but never in quality.
If initially post-translationally modified, the tubulin purified by our protocol maintains all of the commonly studied PTMs (Fig. 4b-d ) and can therefore be used to compare differentially modified microtubules side by side 20, 21 . However, it should be kept in mind, and eventually tested, that the repeated polymerization and depolymerization cycles could bias the composition of the final tubulin. For quantitative analyses of the tubulin composition in cells and tissues, the method by Widlund et al. 29 should be used. The quantities of tubulin obtained by our protocol are sufficient for a wide range of applications. Using a set of four spinner bottles that are maintained continuously, which is possible with HeLa S3 HEK-293 cells have very low levels of tubulin polyglutamylation, TTLL5 overexpression leads to polyglutamylation of both α-and β-tubulin, whereas TTLL7 modifies only β-tubulin. Note that a special acrylamide gel has been used that allows separation of α-and β-tubulin bands that usually co-migrate slightly above 50 kDa 58 . d, Modification levels of tubulin purified from brains of wildtype, atat1 −/− and ttll1 −/− mice. Knockout of aTAT1, the tubulin acetyltransferase 56, 57 , leads to the loss of acetylation of lysine K40 of α-tubulin. Knockout of TTLL1, main brain glutamylase 50 , leads to a reduction of tubulin polyglutamylation. In b, c and d, equal levels of total tubulin were verified with 12G10, an anti-α-tubulin antibody. Experimental procedures involving animals were specifically approved by the ethics committee of the Institut Curie CEEA-IC #118 (authorization no. 04395.03 given by National Authority) in compliance with the international guidelines.
cells that can be constantly diluted without adherent pre-cultures, a laboratory can produce~2 mg of tubulin per week with a work input of~1 d for the tubulin purification. This workload could be even further reduced by collecting cells at −80°C and for a larger-scale tubulin purification. For most TIRF-microscopy-based assays, only microgram amounts of tubulin are needed; thus, the PTM-free HeLa S3 tubulin produced by this protocol could fully replace brain tubulin for an entire research team. Even classic microtubule co-sedimentation assays, although more tubulin-consuming, requirẽ 100 µg of pure tubulin for one dilution series 48, 49 , and can thus easily be performed with tubulin purified with our protocol.
The yield of tubulin from single mouse brains is also sufficient to perform virtually all known in vitro approaches, given that the mouse strain is easy to breed and sufficient numbers of brains can be obtained. The great advantage of purifying tubulin from a single mouse brain is that biological replicates can be introduced in the in vitro approach, as multiple tubulin samples from individual mouse brains can be used side by side.
The most work-intense approach is the purification of tubulin from adherently growing cells. The great advantage of this approach is that it allows generation of virtually any type of post-translationally modified tubulin, given the availability of a wide range of modifying enzymes [50] [51] [52] [53] [54] [55] [56] [57] . We recommend using this method only after an assay has duly been established using brain tubulin or non-modified tubulin from cells grown in spinner cultures, which are easier to produce.
Our protocol thus could allow research teams that perform in vitro reconstitution assays to fully replace brain tubulin with HeLa S3 tubulin, a tubulin free of PTMs and exotic tubulin isotypes, on a daily basis. By expanding the protocol to the purification of tubulin modified with a variety of PTMs, their role can now be directly studied in vitro, which was previously virtually impossible. The proof of principle was provided by the direct comparison of fully tyrosinated and fully detyrosinated HeLa S3 tubulin in single-molecule motility assays and force measurements for the kinetochore kinesin CENP-E (centromere protein E) 20 , binding assays of neuronal kinesin motors 22 , and in transport assays with purified neuronal transport vesicles 21 . These examples demonstrate that PTM-free tubulin obtained by our protocol could be a valid replacement for the brain tubulin used in all currently used in vitro reconstitution assays.
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary.
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